Perspective Therapeutics
CATX
38 hedge funds and large institutions have $3.84M invested in Perspective Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
46% more capital invested
Capital invested by funds: $2.63M → $3.84M (+$1.21M)
23% more funds holding
Funds holding: 31 → 38 (+7)
0.45% more ownership
Funds ownership: 0.62% → 1.07% (+0.45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$816K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$599K |
| 3 |
Renaissance Technologies
New York
|
+$330K |
| 4 |
HPWM
Highland Private Wealth Management
Bellevue,
Washington
|
+$198K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$87.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$10.2K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.26K |
| 3 |
Morgan Stanley
New York
|
-$355 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AAM
26
Auxier Asset Management
Aurora,
Oregon
| $8K | – | – | – |
|
27
Truist Financial
Charlotte,
North Carolina
| $7K | – | – | – |
|
|
NFG
28
Norris Financial Group
Greenville,
South Carolina
| $6.89K | +$9.82K | +1,300 | New |
|
29
State Street
Boston,
Massachusetts
| $6K | – | – | – |
|
|
MC
30
Moors & Cabot
Boston,
Massachusetts
| $5K | – | – | – |
|
|
JFA
31
JNBA Financial Advisors
Bloomington,
Minnesota
| $3K | – | – | – |
|
32
Bank of America
Charlotte,
North Carolina
| $3K | +$3.77K | +500 | New |
|
|
33
Morgan Stanley
New York
| $1K | -$355 | -47 | -32% |
|
34
Osaic Holdings
Scottsdale,
Arizona
| $1K | +$1.13K | +150 | New |
|
|
AIA
35
Arcadia Investment Advisors
Eagle,
Idaho
| $118 | – | – | – |
|
|
WQ
36
Wealth Quarterback
Toms River,
New Jersey
| $70 | – | – | – |
|
|
37
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$5.26K | -697 | -91% |
|
38
Wells Fargo
San Francisco,
California
| – | +$340 | +45 | New |
|
CATX Hedge Fund Activity: Q1 2020 in Review
38 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2020, worth a combined $3.84M — up 46% from $2.63M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CATX positions and 0 closed out — a net gain of 9 holders — while 9 added to existing stakes and 3 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $816K. The largest seller was Citadel Advisors, cutting an estimated $10.2K.
- 38 institutional investors held Perspective Therapeutics (CATX) as of Q1 2020, up from 31 in Q4 2019.
- Funds reported $3.84M of Perspective Therapeutics stock for Q1 2020, up 46% quarter-over-quarter.
- 9 funds opened new Perspective Therapeutics positions in Q1 2020 and 0 closed out, a net change of +9 holders.
- The largest Perspective Therapeutics buyer in Q1 2020 was EAM Investors, an estimated $816K added.
- The largest Perspective Therapeutics seller in Q1 2020 was Citadel Advisors, an estimated $10.2K sold.
Based on aggregated 13F filings for Q1 2020.